Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Endothelial Cell–Activating Antibodies in COVID‐19

17 Feb 2022

Abstract excerpt

OBJECTIVE: While endothelial dysfunction has been implicated in the widespread thromboinflammatory complications of COVID-19, the upstream mediators of endotheliopathy remain, for the most part, unknown. This study was undertaken to identify circulating factors contributing to endothelial cell activation and dysfunction in COVID-19. METHODS: Human endothelial cells were cultured in the presence of serum or plasma...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to COVID-19 Clinical Research Studies
Share to Heparin-Induced Thrombocytopenia and Thrombosis
Share to SARS-CoV-2 and COVID-19 Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35174669
DOI: 10.1002/art.42094

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Endothelial Cell–Activating Antibodies in COVID‐19PMID 35174669Read ↗

Tie2 activation protects against prothrombotic endothelial dysfunction in COVID-19Semantic proximity Read ↗

Vascular underpinning of COVID-19Semantic proximity Read ↗

Systemic inflammation in COVID-19 patients may induce various types of venous and arterial thrombosis: A systematic review.Semantic proximity Read ↗

Cardiovascular Signatures of COVID-19 Predict Mortality and Identify Barrier Stabilizing TherapiesSemantic proximity Read ↗

Interrelationship between COVID-19 and coagulopathy: pathophysiological and clinical evidenceSemantic proximity Read ↗

Transcriptome signatures preceding pulmonary arterial thrombosis in critically ill COVID-19 patientsSemantic proximity Read ↗

SARS-CoV-2 Spike protein promotes vWF secretion and thrombosis via endothelial cytoskeleton-associated protein 4 (CKAP4)Semantic proximity Read ↗

Endothelial Cell Contributions to COVID-19Semantic proximity Read ↗

In situ pulmonary thrombosis and pulmonary embolus are distinct thrombotic phenotypes in critically ill patients with COVID-19 Acute Respiratory Distress Syndrome.Semantic proximity Read ↗

Endothelial activation and dysfunction in COVID-19: from basic mechanisms to potential therapeutic approachesSemantic proximity Read ↗

COVID-19 Sepsis: Pathogenesis and Endothelial Molecular Mechanisms Based on "Two-Path Unifying Theory" of Hemostasis and Endotheliopathy-Associated Vascular Microthrombotic Disease, and Proposed Therapeutic Approach with Antimicrothrombotic Therapy.Semantic proximity Read ↗

IL-1β and TNF drive endothelial dysfunction and coagulopathy in acute COVID-19Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.